BJMO - volume 10, issue 3, may 2016
L. Decoster MD, PhD
Report from the 2015 Annual Meeting of the International Society of Geriatric Oncology (SIOG).
The 2015 Annual Conference of the International Society of Geriatric Oncology took place in Prague, Czech Republic from November 12–14th. More than 400 delegates with a special interest in the care for older patients with cancer attended this conference, including medical oncologists, geriatricians, surgeons, nurses and other professional health care workers. The meeting provided an overview of current advances in geriatric oncology domains.
(BELG J MED ONCOL 2016;10(3):108–9)
Read moreBJMO - volume 8, issue 5, november 2014
L. Decoster MD, PhD
The 2014 annual meeting of the European Society for Medical Oncology (ESMO) featured a number of interesting studies in endocrine and neuroendocrine oncology. This report will first focus on two presentations regarding lenvatinib in the treatment of thyroid cancers. In addition to this, the final OS of the RADIANT-3 study, evaluating everolimus in patients with advanced pancreatic neuroendocrine tumours (NET), will be summarized. The last part of the report will focus on the molecular profiling of NETs and discusses a study assessing the quality of life in NET patients using lanreotide autogel.
(BELG J MED ONCOL 2014;8(4):163–5)
Read moreBJMO - volume 8, issue 5, december 2014
F. Cornélis MD, R. Moor , P. Cornette MD, PhD, L. Decoster MD, PhD, H. Wildiers MD, PhD
As in other developed countries, the management of older cancer patients has become a major public health concern in Belgium owing to an increasing incidence and to other challenging specificities of this population. Since 2009, the Cancer Plan has played a leading role in the development of geriatric oncology in our country by supporting numerous pilot projects. By the year 2015, a scientific analysis of each of these projects will provide important information to the public authorities and care givers in order to organise the management of older cancer patients in an optimal way in Belgium. In this article, we describe the present landscape of geriatric oncology in Belgium focusing on epidemiological data and pilot projects supported by the Cancer Plan 2009–2011 and 2012–2015.
(BELG J MED ONCOL 2014;8(5):206–12)
Read moreBJMO - volume 8, issue 3, july 2014
L. Decoster MD, PhD, F. Cornélis MD, E. Joosens MD, S. Henry MD, P. Specenier MD, PhD, P. Clement MD, PhD, On behalf of the Thyroid Task Force of the BSMO
Thyroid cancers are rare diseases and include types that range from indolent localised differentiated carcinomas to fulminant and lethal anaplastic disease. Until recently, treatment options for advanced or metastatic radio-iodine refractory thyroid cancer were limited. Recently kinase inhibitors targeting angiogenesis and other pathways have shown promising activity.
(BELG J MED ONCOL 2014;8(3):81–6)
Read more
Top
